News

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.
Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...
Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...
Novo Nordisk said Monday it would begin selling its Type 2 diabetes treatment Ozempic directly to consumers at $499 per month ...